4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-22-004765
Options or other derivatives
- VP, Chief Commercial Officer acquired 275,560 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Seth Kiernan · VP, Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-10 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +206,670 | 206,670 | D |
| 2022-02-10 | Grant or award : show line 2 in the form Restricted Stock Units | +68,890 | 68,890 | D |
Loading xslF345X03/form4.xml…